ISLAMABAD, Jan 26 (Online): Here’s one reason why past or current smoking may handicap you if you are battling breast cancer: New research suggests that nicotine promotes the spread of the disease to your lungs.
Smoking is known to increase the risk that breast cancer will spread, which lowers the survival rate by one-third at diagnosis. But the role of nicotine in the spread of breast cancer to the lungs has been less clear.
To learn more, researchers studied almost 1,100 breast cancer patients. They found that current smokers and former smokers had higher rates of breast cancer spread to the lungs than those who never smoked.
In studies of mice, researchers found that nicotine fosters that spread. And this was true even after no exposure to nicotine for 30 days.
That suggests there’s an ongoing risk for breast cancer patients who are former smokers, according to the team from Wake Forest School of Medicine in Winston-Salem, N.C.
Their findings were published online Jan. 20 in the journal Nature Communications.
“Our data shows that nicotine exposure creates an environment in the lungs that is ripe for metastatic growth,” said lead study author Kounosuke Watabe, a professor of cancer biology at Wake Forest.
Long-term exposure to nicotine creates an “inflammatory microenvironment” in the lungs. That attracts immune cells called neutrophils, which release a protein that encourages the spread of cancer, the authors explained.
They also found that salidroside, a natural compound found in the plant Rhodiola rosea, blocks the buildup of neutrophils.
Salidroside has anti-inflammatory, anti-cancer and anti-viral properties. Researchers found it significantly decreased the number of neutrophils and incidence of lung metastases in mice. Results of animal studies may differ in humans.
“Based on these findings, breast cancer patients should opt for smoking cessation programs that do not use nicotine-replacement products,” Watabe said in a Wake Forest news release. “Furthermore, our findings show that salidroside may be a promising therapeutic drug to help prevent smoking-induced breast cancer lung metastasis, although more research is needed.”